We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-1.68%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.43B
AUM Growth
+$172M
Cap. Flow
+$215M
Cap. Flow %
15.04%
Top 10 Hldgs %
3.57%
Holding
2,136
New
582
Increased
568
Reduced
423
Closed
559

Top Sells

Rank Stock Value
1
JBSS icon
John B. Sanfilippo & Son
JBSS
+$3.41M
2
APA icon
APA Corp
APA
+$3.31M
3
ZTS icon
Zoetis
ZTS
+$3.2M
4
UGI icon
UGI
UGI
+$3.03M
5
DOCU
DocuSign
DOCU
+$2.87M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Healthcare 13.4%
3 Consumer Discretionary 13.25%
4 Financials 12.49%
5 Industrials 11.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOD
1001
Gladstone Commercial Corp
GOOD
$627M
$473K 0.03%
33,134
-60,909
-65% -$848K
TENB icon
1002
Tenable Holdings
TENB
$4.01B
$473K 0.03%
+10,864
New +$479K
HIFS icon
1003
Hingham Institution for Saving
HIFS
$663M
$472K 0.03%
2,638
+252
+11% +$43.5K
PPG icon
1004
PPG Industries
PPG
$26.6B
$471K 0.03%
+3,741
New +$496K
RSVR
1005
Reservoir Media
RSVR
$667M
$470K 0.03%
59,504
+4,758
+9% +$37.9K
COOK icon
1006
Traeger
COOK
$172M
$469K 0.03%
3,910
-322
-8% -$37.2K
CWAN
1007
DELISTED
Clearwater Analytics
CWAN
$469K 0.03%
+25,309
New +$457K
MZTI
1008
The Marzetti Company
MZTI
$3.11B
$469K 0.03%
+2,482
New +$474K
PLX icon
1009
Protalix BioTherapeutics
PLX
$198M
$469K 0.03%
401,244
-92,327
-19% -$109K
DAC icon
1010
Danaos Corp
DAC
$2.56B
$468K 0.03%
5,066
-7,606
-60% -$635K
BAX icon
1011
Baxter International
BAX
$14.2B
$467K 0.03%
+13,962
New +$515K
SPTN
1012
DELISTED
SpartanNash
SPTN
$467K 0.03%
+24,884
New +$485K
ECPG icon
1013
Encore Capital Group
ECPG
$2.13B
$465K 0.03%
11,145
-11,274
-50% -$486K
WST icon
1014
West Pharmaceutical
WST
$24.9B
$465K 0.03%
+1,413
New +$499K
FSTA icon
1015
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.42B
$463K 0.03%
9,761
+2,956
+43% +$140K
ATHM icon
1016
Autohome
ATHM
$2.62B
$461K 0.03%
16,800
-16,474
-50% -$447K
RELL icon
1017
Richardson Electronics
RELL
$304M
$461K 0.03%
38,804
-56,855
-59% -$606K
TRMB icon
1018
Trimble
TRMB
$13.9B
$461K 0.03%
+8,246
New +$476K
RCKY icon
1019
Rocky Brands
RCKY
$369M
$460K 0.03%
12,457
-6,890
-36% -$227K
XEL icon
1020
Xcel Energy
XEL
$48.8B
$459K 0.03%
+8,593
New +$467K
SRPT icon
1021
Sarepta Therapeutics
SRPT
$1.77B
$458K 0.03%
2,896
-2,156
-43% -$277K
NOMD icon
1022
Nomad Foods
NOMD
$1.68B
$457K 0.03%
27,727
+16,145
+139% +$291K
RPV icon
1023
Invesco S&P 500 Pure Value ETF
RPV
$1.68B
$456K 0.03%
+5,464
New +$463K
NBP
1024
NovaBridge Biosciences American Depositary Shares
NBP
$202M
$455K 0.03%
272,193
-160,428
-37% -$287K
ULBI icon
1025
Ultralife
ULBI
$106M
$455K 0.03%
42,808
+25,471
+147% +$271K

Similar funds

GSA Capital Partners's Q2 2024 Portfolio in Review

As of Q2 2024, GSA Capital Partners held 2,136 positions worth $1.43B, up 14% from $1.26B the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.

GSA Capital Partners deployed $215M of net new capital in Q2 2024, opening 582 new positions and adding to 568 existing holdings. Its largest new stake was Genuine Parts: 28,253 shares worth $3.91M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was UGI, an estimated $3.03M trimmed.

  • GSA Capital Partners's largest Q2 2024 buy was Genuine Parts: 28,253 shares worth $3.91M.
  • GSA Capital Partners added most to Devon Energy in Q2 2024, an estimated $5.97M increase.
  • GSA Capital Partners's biggest Q2 2024 reduction was UGI, cutting an estimated $3.03M.
  • GSA Capital Partners fully exited John B. Sanfilippo & Son in Q2 2024, selling an estimated $3.41M.
  • GSA Capital Partners's ten largest holdings make up 3.6% of its $1.43B portfolio in Q2 2024.
  • GSA Capital Partners opened 582 new positions and closed 559 in Q2 2024.
  • GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $1.43B.

Based on GSA Capital Partners's 13F filing for Q2 2024, filed 15 Aug 2024.